Contrasting Innophos Holdings (IPHS) & Its Peers
Innophos Holdings (NASDAQ: IPHS) is one of 34 publicly-traded companies in the “Commodity Chemicals” industry, but how does it compare to its competitors? We will compare Innophos Holdings to related businesses based on the strength of its valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.
This is a summary of recent ratings and recommmendations for Innophos Holdings and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Innophos Holdings Competitors||104||772||1154||34||2.54|
Innophos Holdings currently has a consensus target price of $56.00, indicating a potential upside of 13.29%. As a group, “Commodity Chemicals” companies have a potential downside of 1.45%. Given Innophos Holdings’ stronger consensus rating and higher possible upside, analysts clearly believe Innophos Holdings is more favorable than its competitors.
Innophos Holdings pays an annual dividend of $1.92 per share and has a dividend yield of 3.9%. Innophos Holdings pays out 84.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Commodity Chemicals” companies pay a dividend yield of 1.8% and pay out 63.1% of their earnings in the form of a dividend.
This table compares Innophos Holdings and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Innophos Holdings Competitors||-23.86%||24.81%||5.91%|
Risk & Volatility
Innophos Holdings has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Comparatively, Innophos Holdings’ competitors have a beta of 1.17, indicating that their average share price is 17% more volatile than the S&P 500.
Institutional & Insider Ownership
94.3% of Innophos Holdings shares are owned by institutional investors. Comparatively, 69.0% of shares of all “Commodity Chemicals” companies are owned by institutional investors. 2.3% of Innophos Holdings shares are owned by company insiders. Comparatively, 8.2% of shares of all “Commodity Chemicals” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares Innophos Holdings and its competitors top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Innophos Holdings||$698.91 million||$116.47 million||21.68|
|Innophos Holdings Competitors||$4.16 billion||$893.20 million||33.82|
Innophos Holdings’ competitors have higher revenue and earnings than Innophos Holdings. Innophos Holdings is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Innophos Holdings competitors beat Innophos Holdings on 8 of the 15 factors compared.
About Innophos Holdings
Innophos Holdings, Inc. is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other. The Company has four principal product lines: Specialty Ingredients; Food and Technical Grade Purified Phosphoric Acid (PPA); Technical Grade Sodium Tripolyphosphate (STPP), & Detergent Grade PPA, and GTSP & Other. The Company’s bioactive mineral ingredients are mineral-based ingredients for food, beverage and dietary supplement end markets that are manufactured to be readily digestible. The Company has its manufacturing facilities located throughout the United States, Canada, Mexico and China.
Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.